Pharma deals drive dollar issuance in post-election rush

The corporate dollar market roared back to life this week following the US presidential elections, with pharmaceuticals companies leading the charge as the Treasury market sell-off worked to the advantage of high grade issuers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: